187 related articles for article (PubMed ID: 24078265)
1. Dynactin Deficiency in the CNS of Humans with Sporadic ALS and Mice with Genetically Determined Motor Neuron Degeneration.
Kuźma-Kozakiewicz M; Chudy A; Kaźmierczak B; Dziewulska D; Usarek E; Barańczyk-Kuźma A
Neurochem Res; 2013 Sep; 38(12):2463-73. PubMed ID: 24078265
[TBL] [Abstract][Full Text] [Related]
2. Differences in glutathione S-transferase pi expression in transgenic mice with symptoms of neurodegeneration.
Kaźmierczak B; Kuźma-Kozakiewicz M; Usarek E; Barańczyk-Kuźma A
Acta Biochim Pol; 2011; 58(4):621-6. PubMed ID: 22132373
[TBL] [Abstract][Full Text] [Related]
3. Kinesin expression in the central nervous system of humans and transgenic hSOD1G93A mice with amyotrophic lateral sclerosis.
Kuźma-Kozakiewicz M; Chudy A; Gajewska B; Dziewulska D; Usarek E; Barańczyk-Kuźma A
Neurodegener Dis; 2013; 12(2):71-80. PubMed ID: 23006449
[TBL] [Abstract][Full Text] [Related]
4. Changes in kinesin expression in the CNS of mice with dynein heavy chain 1 mutation.
Kuźma-Kozakiewicz M; Kaźmierczak B; Usarek E; Barańczyk-Kuźma A
Acta Biochim Pol; 2013; 60(1):51-5. PubMed ID: 23460941
[TBL] [Abstract][Full Text] [Related]
5. Alteration of Motor Protein Expression Involved in Bidirectional Transport in Peripheral Blood Mononuclear Cells of Patients with Amyotrophic Lateral Sclerosis.
Kuźma-Kozakiewicz M; Kaźmierczak B; Chudy A; Gajewska B; Barańczyk-Kuźma A
Neurodegener Dis; 2016; 16(3-4):235-44. PubMed ID: 26954557
[TBL] [Abstract][Full Text] [Related]
6. Mice with mutation in dynein heavy chain 1 do not share the same tau expression pattern with mice with SOD1-related motor neuron disease.
Kuźma-Kozakiewicz M; Usarek E; Ludolph AC; Barańczyk-Kuźma A
Neurochem Res; 2011 Jun; 36(6):978-85. PubMed ID: 21380844
[TBL] [Abstract][Full Text] [Related]
7. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
[TBL] [Abstract][Full Text] [Related]
8. Effects of ALS-related SOD1 mutants on dynein- and KIF5-mediated retrograde and anterograde axonal transport.
Shi P; Ström AL; Gal J; Zhu H
Biochim Biophys Acta; 2010 Sep; 1802(9):707-16. PubMed ID: 20510358
[TBL] [Abstract][Full Text] [Related]
9. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking.
Laird FM; Farah MH; Ackerley S; Hoke A; Maragakis N; Rothstein JD; Griffin J; Price DL; Martin LJ; Wong PC
J Neurosci; 2008 Feb; 28(9):1997-2005. PubMed ID: 18305234
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain.
Gregory JM; Livesey MR; McDade K; Selvaraj BT; Barton SK; Chandran S; Smith C
J Pathol; 2020 Jan; 250(1):67-78. PubMed ID: 31579943
[TBL] [Abstract][Full Text] [Related]
11. [Role of axonal transport in ALS].
Tanaka F; Ikenaka K; Sobue G
Rinsho Shinkeigaku; 2011 Nov; 51(11):1189-91. PubMed ID: 22277530
[TBL] [Abstract][Full Text] [Related]
12. Neuropathology and omics in motor neuron diseases.
Tanaka F; Ikenaka K; Yamamoto M; Sobue G
Neuropathology; 2012 Aug; 32(4):458-62. PubMed ID: 22187969
[TBL] [Abstract][Full Text] [Related]
13. dnc-1/dynactin 1 knockdown disrupts transport of autophagosomes and induces motor neuron degeneration.
Ikenaka K; Kawai K; Katsuno M; Huang Z; Jiang YM; Iguchi Y; Kobayashi K; Kimata T; Waza M; Tanaka F; Mori I; Sobue G
PLoS One; 2013; 8(2):e54511. PubMed ID: 23408943
[TBL] [Abstract][Full Text] [Related]
14. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
15. Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice.
Qiu L; Qiao T; Beers M; Tan W; Wang H; Yang B; Xu Z
Mol Neurodegener; 2013 Jan; 8():1. PubMed ID: 23281774
[TBL] [Abstract][Full Text] [Related]
16. [Exploration of pathogenesis-associated molecules and development of disease models for sporadic ALS].
Tanaka F; Waza M; Niwa J; Yamamoto M; Sobue G
Rinsho Shinkeigaku; 2008 Nov; 48(11):970-2. PubMed ID: 19198134
[TBL] [Abstract][Full Text] [Related]
17. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
[TBL] [Abstract][Full Text] [Related]
18. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS.
Ayers JI; Diamond J; Sari A; Fromholt S; Galaleldeen A; Ostrow LW; Glass JD; Hart PJ; Borchelt DR
Acta Neuropathol; 2016 Dec; 132(6):827-840. PubMed ID: 27704280
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
20. A dynein mutation attenuates motor neuron degeneration in SOD1(G93A) mice.
Teuchert M; Fischer D; Schwalenstoecker B; Habisch HJ; Böckers TM; Ludolph AC
Exp Neurol; 2006 Mar; 198(1):271-4. PubMed ID: 16427626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
